Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Solventum's total debt was $5.07B at Sep 30, 2026. For fiscal 2025 it was $5.04B, down 37.1% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.04B | -37.1% |
| FY2024 | Dec 31, 2024 | $8.01B | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.07B | -1.3% |
| Q2 FY2026 | Jun 30, 2026 | $5.08B | -35.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.08B | -35.8% |
| Q4 FY2025 | Dec 31, 2025 | $5.04B | -37.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.14B | -36.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.82B | -5.9% |
| Q1 FY2025 | Mar 31, 2025 | $7.91B | -4.7% |
| Q4 FY2024 | Dec 31, 2024 | $8.01B | – |
| Q3 FY2024 | Sep 30, 2024 | $8.11B | – |
| Q2 FY2024 | Jun 30, 2024 | $8.31B | – |
| Q1 FY2024 | Mar 31, 2024 | $8.30B | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
See a number that looks wrong?